Impact of postoperative intravenous iron therapy on postoperative infections in older patients with severe anaemia after hip fracture surgery.

Geriatric patients Intravenous iron Postoperative anaemia Postoperative infections Surgery

Journal

BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548

Informations de publication

Date de publication:
14 02 2023
Historique:
received: 27 06 2022
accepted: 27 01 2023
entrez: 15 2 2023
pubmed: 16 2 2023
medline: 17 2 2023
Statut: epublish

Résumé

Anaemia is common following hip fracture in ortho-geriatric patients and is associated with postoperative infections.. This study investigated whether intravenous iron supplements reduced the rate of postoperative infections within 30 days postoperatively in older adults after hip fracture surgery. This observational study included 198 ortho-geriatric patients July 2018-May 2020. In May 2019 a local guideline was implemented and recommended II therapy on the 3 The patients were divided into four treatment groups: blood transfusion (n = 44), IV iron (n = 69), blood transfusion + IV iron (n = 35) and no treatment (n = 50). The number of patients who had an infection within 30 days was similar in the two time periods (38.8% before vs. 38.9% after systematic I.V. iron supplementation, P = 1.00) and no significant difference according to risk of infection was found between treatment groups. This study documents no effect of intravenous iron supplements on postoperative infections in older adults after hip fracture surgery. The study was registered with the Danish Data Protection Authority (2008-58-0028) the 2

Sections du résumé

BACKGROUND
Anaemia is common following hip fracture in ortho-geriatric patients and is associated with postoperative infections.. This study investigated whether intravenous iron supplements reduced the rate of postoperative infections within 30 days postoperatively in older adults after hip fracture surgery.
METHODS
This observational study included 198 ortho-geriatric patients July 2018-May 2020. In May 2019 a local guideline was implemented and recommended II therapy on the 3
RESULTS
The patients were divided into four treatment groups: blood transfusion (n = 44), IV iron (n = 69), blood transfusion + IV iron (n = 35) and no treatment (n = 50). The number of patients who had an infection within 30 days was similar in the two time periods (38.8% before vs. 38.9% after systematic I.V. iron supplementation, P = 1.00) and no significant difference according to risk of infection was found between treatment groups.
CONCLUSION
This study documents no effect of intravenous iron supplements on postoperative infections in older adults after hip fracture surgery.
TRIAL REGISTRATION
The study was registered with the Danish Data Protection Authority (2008-58-0028) the 2

Identifiants

pubmed: 36788483
doi: 10.1186/s12877-023-03775-8
pii: 10.1186/s12877-023-03775-8
pmc: PMC9930316
doi:

Substances chimiques

perferryl iron 14127-54-9
Iron E1UOL152H7

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95

Informations de copyright

© 2023. The Author(s).

Références

Bone. 2019 Oct;127:563-570
pubmed: 31340186
Anaesthesia. 2015 Apr;70(4):483-500
pubmed: 25764405
Lancet Haematol. 2016 Sep;3(9):e415-25
pubmed: 27570088
Transfusion. 2014 Feb;54(2):289-99
pubmed: 23581484
Geriatr Orthop Surg Rehabil. 2020 Jun 26;11:2151459320935094
pubmed: 32637197
Blood Transfus. 2022 Jul;20(4):310-318
pubmed: 34694223
Osteoporos Int. 2012 Sep;23(9):2239-56
pubmed: 22419370
Transfusion. 2011 Jan;51(1):97-104
pubmed: 20630042
Expert Opin Drug Deliv. 2017 Dec;14(12):1439-1446
pubmed: 29032713
J Orthop Surg Res. 2021 May 18;16(1):320
pubmed: 34006287
Injury. 2012 Jun;43(6):676-85
pubmed: 21683355
J Trauma. 2003 May;54(5):908-14
pubmed: 12777903
Arch Orthop Trauma Surg. 2005 Jun;125(5):342-7
pubmed: 15789233

Auteurs

Lene T Hansen (LT)

Department of Geriatric Medicine, North Denmark Regional Hospital, Hjørring, Denmark. dmk@rn.dk.

Johannes Riis (J)

North Denmark Regional Hospital, Hjørring, Denmark.

Kristian H Kragholm (KH)

North Denmark Regional Hospital, Hjørring, Denmark.
Unit of Clinical Biostatistics and Epidemiology, Aalborg University Hospital, Aalborg, Denmark.
Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Lis K Larsen (LK)

Department of Orthopedic Surgery, Aalborg University Hospital, Hjørring, Denmark.

Christian Cavallius (C)

Department of Orthopedic Surgery, Aalborg University Hospital, Hjørring, Denmark.

Marianne M Mørch (MM)

Department of Geriatric Medicine, North Denmark Regional Hospital, Hjørring, Denmark.

Silas Z Clemmensen (SZ)

North Denmark Regional Hospital, Hjørring, Denmark.
Department of Orthopedic Surgery, Aalborg University Hospital, Hjørring, Denmark.

Maria L Krogager (ML)

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Department of Emergency Medicine, Aalborg University Hospital, Aalborg, Denmark.

Dorte Melgaard (D)

North Denmark Regional Hospital, Hjørring, Denmark. dmk@rn.dk.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. dmk@rn.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH